Cancer risk associated with DPP4 inhibitors in type 2 diabetes: A pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) - Wan Xiong; Yilin Li; Juanjuan Huang; Gefei He; Ji Sun (PLoS ONE, 2026)